Context of anesthesia depth and pharyngeal relaxation at the drug-induced sleep endoscopy in patients with sleep-disordered breathing.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004560

Enrollment

Registered

2013-03-26

Start date

2011-10-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.39

Interventions

Group 1: Patients are treated in accordance with current standards in sleep apnea diagnosis on anaesthesiological site by RR, ECG and SpO2 monitoring. By ENT hand, during a stepwise sedation using pro

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Presence of a sleep-related breathing disorder with the indication for sleep-induced endoscopy 2. Consent of the patient

Exclusion criteria

Exclusion criteria: 1. Patients under 18 years 2. Lack of Informed Consent 3. Lack of indication for the sleep-induced endoscopy 4. Contraindication to the drug-induced sleep endoscopy (eg, anesthesia-related aspiration, obesity permagna)

Design outcomes

Primary

Measure	Time frame
Correlation of the depth of sedation in drug-induced sleep endoscopy with the pharyngeal relaxation in patients with sleep-related breathing disorders (SBAS).	—

Secondary

Measure	Time frame
1. Evaluation of the required dose of medication to achieve a certain level of sedation with respect to the expression of a SBAS (measured in the Polygrahia). 2. Analyse the acoustic characteristics of the induced snoring, depending on the depth of sedation.	—

Countries

Germany

Contacts

Public ContactMichael Herzog

Universitätsklinikum Halle (Saale) Universitätsklinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie

michael.herzog@uk-halle.de+49/345/557-1217

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026